Steve O'loughlin

Chief Financial Officer at Actinium Pharmaceuticals Inc. (ATNM), 2025-04-02
Vp, Corp Finance & Development at Protea Biosciences Group Inc. (PRGB), 2014-08-14

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
ATNM	$0.44	10,000	$4,350.00	35,500	2018-12-10	Filing
ATNM	$0.50	12,000	$6,000.00	25,500	2018-06-15	Filing
ATNM	$1.17	3,500	$4,095.00	3,500	2017-06-15	Filing